OFI Officina Farmaceutica Italiana SpA
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
OFI Officina Farmaceutica Italiana SpA - overview
Established
1946
Location
Bergamo, -, Italy
Primary Industry
Pharmaceuticals
About
Founded in 1946 and based in Bergamo, Italy, OFI Officina Farmaceutica Italiana SpA operates as a pharmaceutical company that develops and manufactures skin cosmetics, nutritional supplements and medical devices.
Current Investors
Alto Partners
Primary Industry
Pharmaceuticals
Sub Industries
Medical Devices & Equipment, Pharmaceutical Research & Development
Website
www.ofi.it
Verticals
Manufacturing
Total Amount Raised
Subscriber access only
OFI Officina Farmaceutica Italiana SpA - financials
| Fiscal Year Ended | Dec 31, 2010 | Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 12,150,212 | 11,987,050 | 11,767,555 | 11,803,599 | 12,878,127 | 13,404,106 | 15,263,624 | 16,230,411 | 17,956,501 | 18,545,478 | 17,489,891 | 15,055,319 | - | - | - |
| % Revenue Growth (YoY) | - | (1.3%) | (1.8%) | 0.3% | 9.1% | 4.1% | 13.9% | 6.3% | 10.6% | 3.3% | (5.7%) | (13.9%) | - | - | - |
| EBITDA (USD) | 631,233 | 551,408 | 423,209 | 720,936 | 865,435 | 1,140,177 | 1,290,455 | 2,358,667 | 2,809,230 | 3,652,505 | 3,276,130 | 3,450,238 | - | - | - |
| Operating Income (USD) | 334,136 | 341,147 | 174,300 | 432,330 | 550,057 | 639,640 | 828,569 | 1,958,080 | 2,456,390 | 3,208,344 | 1,507,781 | 1,633,061 | - | - | - |
| Operating Margin | 2.8% | 2.8% | 1.5% | 3.7% | 4.3% | 4.8% | 5.4% | 12.1% | 13.7% | 17.3% | 8.6% | 10.8% | - | - | - |
| % EBITDA Margin | 5.2% | 4.6% | 3.6% | 6.1% | 6.7% | 8.5% | 8.5% | 14.5% | 15.6% | 19.7% | 18.7% | 22.9% | - | - | - |
| NET Income (USD) | 81,751 | 48,873 | 69,084 | (200,498) | 72,131 | 103,166 | 228,810 | 1,198,116 | 1,632,359 | 2,163,917 | 527,919 | 771,361 | - | - | - |
| % Net Margin | 0.7% | 0.4% | 0.6% | (1.7%) | 0.6% | 0.8% | 1.5% | 7.4% | 9.1% | 11.7% | 3.0% | 5.1% | - | - | - |
OFI Officina Farmaceutica Italiana SpA - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Completed | OFI Officina Farmaceutica Italiana SpA | - | ||||||||
| Growth | Completed | OFI Officina Farmaceutica Italiana SpA | - | ||||||||
| Unspecified Exit | Completed | OFI Officina Farmaceutica Italiana SpA | - |
Displaying 1 - 3 of 3
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.